Need help finding what you are looking for?
Contact Us
PUBLISHER: Grand View Research | PRODUCT CODE: 1114019
PUBLISHER: Grand View Research | PRODUCT CODE: 1114019
Hormone Replacement Therapy Market Size, Share & Trend Analysis By Product (Estrogen & Progesterone Replacement Therapy), By Route Of Administration, By Disease Type, By Region, and Segment Forecasts, 2022 - 2030
PUBLISHED:
PAGES: 123 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Hormone Replacement Therapy Market Growth & Trends:
The global hormone replacement therapy market is expected to reach USD 35.79 billion by 2030, according to a new study by Grand View Research, Inc. expanding at a CAGR of 6.4% from 2022 to 2030. The growth in the hormone replacement therapy market is largely attributable to the rising prevalence of hormonal disorders coupled with technological advancements in drug delivery systems. According to the National Organization of Rare Diseases, there are around 70,000 people with hypoparathyroidism in the U.S.
Technological advancements to minimize the side effects and enhance drug bioavailability are expected to boost the market growth. Due to better bioavailability, the treatment frequency increases. Products such as NGENLA, which is used to treat growth hormone deficiency, require a once-a-week dosage, which ensures better patient compliance. Furthermore, improvement in the route of administration is expected to boost the adoption of products. For instance, intranasal estrogen medication such as Nafarelin is comparatively more compliant in women than the conventional method.
Companies are taking initiatives such as collaboration, partnership, and agreement to expand their business footprint and generate revenue. For instance, in September 2021, Merck & Co., Inc. entered into an agreement with BIOCORP, a French company, for the development and distribution of the HGH monitoring device, Mallya. It is used to monitor and track daily HCG treatment. Such strategies are anticipated to propel the market growth during the forecast period.
Moreover, the launch of new hormone replacement therapy medicines in the market is anticipated to drive market growth. For instance, in November 2021, Fuji Pharma Co, Ltd. announced the launch of F-meno (100 mg capsule) for the prevention of endometrial hyperplasia on the administration of estrogen drugs for menopausal disorders. F-memo is an orally administered drug and is included in Japan's National Health Insurance Drug Price list. This initiative may boost the prescription rate for hormone replacement therapy drugs, thereby driving the market growth.
However, severe adverse effects act as key restraints for market growth. The FDA has identified certain drugs in estrogen therapy that can cause adverse reactions and increase the risk of cancer in women. Premarin and Prempro, manufactured by Pfizer, are found to be associated with inducing cancer.
Hormone Replacement Therapy Market Highlights:
- Based on the product, the estrogen & progesterone replacement therapy segment dominated the market in 2021 and is estimated to maintain its dominance during the forecast period due to high demand due to the increasing number of women reaching menopause
- Parathyroid hormone replacement therapy is anticipated to witness the fastest growth during the forecast period due to the rising adoption of hormone replacement for the treatment of hypoparathyroidism
- Based on the route of administration, the oral segment dominated the market in 2021 owing to the high prescription rate. Around 120 million prescriptions of Levothyroxine sodium tablets are being dispensed annually in the U.S
- Parenteral is expected to witness the fastest growth. The development and approval of long-acting products are expected to boost segment growth. For instance, in October 2021, Pfizer, Inc. received approval for its NGENLA (somatrogon), a once-a-week long-acting recombinant human growth hormone, from Health Canada for the treatment of a patient with growth hormone deficiency
- Menopause disease type segment dominated the market in 2021 due to the rising number of women in the age group of 45 to 60 years and increasing incidence of vasomotor symptoms that may lead to severe conditions, such as osteoporosis, which are projected to fuel market growth
Product Code: 978-1-68038-784-1
Table of Contents
Chapter 1 Methodology and Scope
- 1.1 Market Segmentation
- 1.1.1 Estimates and Forecast Timeline
- 1.2 Research Methodology
- 1.3 Information procurement
- 1.3.1 Purchased Database
- 1.3.2 GVR's Internal Database
- 1.3.3 Secondary Sources
- 1.3.4 Primary Research
- 1.3.5 Details of Primary Research
- 1.4 Information or Data Analysis
- 1.4.1 Data Analysis Models
- 1.5 Market Formulation & Validation
- 1.6 Model Details
- 1.6.1 Commodity Flow Analysis
- 1.6.1.1 Approach 1: Commodity Flow Approach
- 1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
- 1.6.1 Commodity Flow Analysis
- 1.7 Global Market: CAGR Calculation
- 1.8 Research Assumptions
- 1.9 List of Secondary Sources
- 1.10 List of Primary Sources
- 1.11 List of Abbreviations
- 1.12 Objectives
- 1.12.1 Objective 1
- 1.12.2 Objective 2
- 1.12.3 Objective 3
- 1.12.4 Objective 4
Chapter 2 Executive Summary
- 2.1 Market Snapshot
Chapter 3 Market Variables, Trends, & Scope
- 3.1 Market Lineage Outlook
- 3.1.1 Parent Market Outlook
- 3.2 Penetration & Growth Prospect Mapping
- 3.3 Regulatory and Reimbursement Framework
- 3.4 Market Variable Analysis
- 3.4.1 Market driver analysis
- 3.4.1.1 Rising prevalence of hormonal disorders and increasing number of patients undergoing hormone replacament therapy
- 3.4.1.2 Technological developments in drug delivery systems
- 3.4.1.3 Increasing R&D investments and rising awareness about hormone deficiency
- 3.4.2 Market restraint analysis
- 3.4.2.1 High cost of treatment
- 3.4.2.2 Risk of side effects
- 3.4.1 Market driver analysis
- 3.5 Industry Analysis Tools
- 3.5.1 Porter's five forces analysis
- 3.6 Industry Analysis Tools
- 3.6.1 PESTEL Analysis
- 3.7 Pipeline Analysis
Chapter 4 Hormone Replacement Therapy Market - Segment Analysis, by Product Type, 2018 - 2030 (USD Billion)
- 4.1 HRT Market: Product Movement Analysis
- 4.2 Estrogen & Progesterone Replacement Therapy
- 4.2.1 Estrogen & Progesterone replacement therapy market, 2018 - 2030 (USD Billion)
- 4.3 Human Growth Hormone (HGH) Replacement Therapy
- 4.3.1 HGH replacement therapy market, 2018 - 2030 (USD Billion)
- 4.4 Thyroid Hormone Replacement Therapy
- 4.4.1 Thyroid hormone replacement therapy market, 2018 - 2030 (USD Billion)
- 4.5 Testosterone Replacement Therapy
- 4.5.1 Testosterone replacement therapy market, 2018 - 2030 (USD Billion)
- 4.6 Parathyroid Hormone Replacement
- 4.6.1 Parathyroid Hormone Replacement market, 2018 - 2030 (USD Billion)
Chapter 5 Hormone Replacement Therapy Market - Segment Analysis, by Route of Administration, 2018 - 2030 (USD Billion)
- 5.1 HRT Market: Route of Administration Movement Analysis
- 5.2 Oral
- 5.2.1 Oral market, 2018 - 2030 (USD Billion)
- 5.3 Parenteral
- 5.3.1 Parenteral market, 2018 - 2030 (USD Billion)
- 5.4 Transdermal
- 5.4.1 Transdermal market, 2018 - 2030 (USD Billion)
- 5.5 Others
- 5.5.1 Others market, 2018 - 2030 (USD Billion)
Chapter 6 Hormone Replacement Therapy Market - Segment Analysis, by Disease Type, 2018 - 2030 (USD Billion)
- 6.1 HRT Market: Disease Type Movement Analysis
- 6.2 Menopause
- 6.2.1 Menopause market, 2018 - 2030 (USD Billion)
- 6.3 Hypothyroidism
- 6.3.1 Hypothyroidism market, 2018 - 2030 (USD Billion)
- 6.4 Male Hypogonadism
- 6.4.1 Male Hypogonadism market, 2018 - 2030 (USD Billion)
- 6.5 Growth Hormone Deficiency
- 6.5.1 Growth Hormone Deficiency market, 2018 - 2030 (USD Billion)
- 6.6 Hypoparathyroidism
- 6.6.1 Hypoparathyroidism, 2018 - 2030 (USD Billion)
Chapter 7 Hormone Replacement Therapy Market - Segment Analysis, By Region, 2018 - 2030 (USD Billion)
- 7.1 Hormone Replacement Therapy Market, Market Share by Region, 2021 & 2030
- 7.1.1 North America
- 7.1.1.1 North America market estimates and forecast, 2018 - 2030 (USD Billion)
- 7.1.1.2 U.S.
- 7.1.1.2.1 U.S. market estimates and forecast, 2018 - 2030 (USD Billion)
- 7.1.1.3 Canada
- 7.1.1.3.1 Canada market estimates and forecast, 2018 - 2030 (USD Billion)
- 7.1.2 Europe
- 7.1.2.1 Europe market estimates and forecast, 2018 - 2030 (USD Billion)
- 7.1.2.2 UK
- 7.1.2.2.1 UK market estimates and forecast, 2018 - 2030 (USD Billion)
- 7.1.2.3 Germany
- 7.1.2.3.1 Germany market estimates and forecast, 2018 - 2030 (USD Billion)
- 7.1.2.4 France
- 7.1.2.4.1 France market estimates and forecast, 2018 - 2030 (USD Billion)
- 7.1.2.5 Spain
- 7.1.2.5.1 Spain market estimates and forecast, 2018 - 2030 (USD Billion)
- 7.1.2.6 Italy
- 7.1.2.6.1 Italy market estimates and forecast, 2018 - 2030 (USD Billion)
- 7.1.3 Asia-Pacific
- 7.1.3.1 Asia-Pacific market estimates and forecast, 2018 - 2030 (USD Billion)
- 7.1.3.2 Japan
- 7.1.3.2.1 Japan market estimates and forecast, 2018 - 2030 (USD Billion)
- 7.1.3.3 China
- 7.1.3.3.1 China market estimates and forecast, 2018 - 2030 (USD Billion)
- 7.1.3.4 India
- 7.1.3.4.1 India market estimates and forecast, 2018 - 2030 (USD Billion)
- 7.1.3.5 Australia
- 7.1.3.5.1 Australia market estimates and forecast, 2018 - 2030 (USD Billion)
- 7.1.3.6 South Korea
- 7.1.3.6.1 South Korea market estimates and forecast, 2018 - 2030 (USD Billion)
- 7.1.4 Latin America
- 7.1.4.1 Latin America market estimates and forecast, 2018 - 2030 (USD Billion)
- 7.1.4.2 Brazil
- 7.1.4.2.1 Brazil market estimates and forecast, 2018 - 2030 (USD Billion)
- 7.1.4.3 Mexico
- 7.1.4.3.1 Mexico market estimates and forecast, 2018 - 2030 (USD Billion)
- 7.1.4.4 Argentina
- 7.1.4.4.1 Argentina market estimates and forecast, 2018 - 2030 (USD Billion)
- 7.1.5 Middle East and Africa
- 7.1.5.1 Middle East and Africa market estimates and forecast, 2018 - 2030 (USD Billion)
- 7.1.5.2 South Africa
- 7.1.5.2.1 South Africa market estimates and forecast, 2018 - 2030 (USD Billion)
- 7.1.5.3 Saudi Arabia
- 7.1.5.3.1 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Billion)
- 7.1.5.4 UAE
- 7.1.5.4.1 UAE market estimates and forecast, 2018 - 2030 (USD Billion)
- 7.1.1 North America
Chapter 8 Hormone Replacement Therapy Market - Competitive Analysis
- 8.1 Major Deals and Strategic Alliances Analysis
- 8.1.1 New Product Launch
- 8.1.2 Mergers and Acquisitions
- 8.1.3 Partnerships and Strategic Collaborations
- 8.1.4 Conferences and Campaigns
- 8.2 Company Categorization
- 8.2.1 Market Differentiators
- 8.2.2 Innovators
- 8.2.3 Market Leaders
- 8.3 Vendor Landscape
- 8.3.1 List of key distributors and channel partners
- 8.3.2 Key customers
- 8.4 Heat map analysis
- 8.5 Public Companies
- 8.5.1 Key company market share analysis, 2021
- 8.5.2 Company Market Position Analysis
- 8.6 Private Companies
- 8.6.1 List of key emerging companies
- 8.6.2 Regional Network Map
- 8.7 Company Profiles
- 8.7.1 Bayer AG
- 8.7.1.1 Company overview
- 8.7.1.2 Financial performance
- 8.7.1.3 Product benchmarking
- 8.7.1.4 Strategic initiatives
- 8.7.2 Pfizer, Inc.
- 8.7.2.1 Company overview
- 8.7.2.2 Financial performance
- 8.7.2.3 Product benchmarking
- 8.7.2.4 Strategic initiatives
- 8.7.3 Merck & Co., Inc.
- 8.7.3.1 Company overview
- 8.7.3.2 Financial performance
- 8.7.3.3 Product benchmarking
- 8.7.3.4 Strategic initiatives
- 8.7.4 Viatris Inc.
- 8.7.4.1 Company overview
- 8.7.4.2 Financial performance
- 8.7.4.3 Product benchmarking
- 8.7.4.4 Strategic initiatives
- 8.7.5 Novo Nordisk A/S
- 8.7.5.1 Company overview
- 8.7.5.2 Financial performance
- 8.7.5.3 Product benchmarking
- 8.7.5.4 Strategic initiatives
- 8.7.6 Eli Lilly and Company
- 8.7.6.1 Company overview
- 8.7.6.2 Financial performance
- 8.7.6.3 Product benchmarking
- 8.7.6.4 Strategic initiatives
- 8.7.7 F. Hoffmann-La Roche Ltd. (Genentech)
- 8.7.7.1 Company overview
- 8.7.7.2 Financial performance
- 8.7.7.3 Product benchmarking
- 8.7.8 Hisamitsu Pharmaceutical Co., Inc. (Noven Pharmaceuticals, Inc.)
- 8.7.8.1 Company overview
- 8.7.8.2 Financial performance
- 8.7.8.3 Product benchmarking
- 8.7.8.4 Strategic initiatives
- 8.7.9 ASCEND Therapeutics US, LLC. (Besins Healthcare)
- 8.7.9.1 Company overview
- 8.7.9.2 Product benchmarking
- 8.7.9.3 Strategic initiatives
- 8.7.10 AbbVie Inc.
- 8.7.10.1 Company overview
- 8.7.10.2 Financial performance
- 8.7.10.3 Product benchmarking
- 8.7.10.4 Strategic initiatives
- 8.7.1 Bayer AG
Product Code: 978-1-68038-784-1
List of Tables
- Table 1 List of secondary sources
- Table 2 List of abbreviations
- Table 3 Regulatory framework
- Table 4 Leading market players anticipated witnessing the highest growth
- Table 5 List of key distributors and compounding pharmacies
- Table 6 North America hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
- Table 7 North America hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
- Table 8 North America hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
- Table 9 U.S. hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
- Table 10 U.S. hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
- Table 11 U.S. hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
- Table 12 Canada hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
- Table 13 Canada hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
- Table 14 Canada hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
- Table 15 Europe hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
- Table 16 Europe hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
- Table 17 Europe hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
- Table 18 UK hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
- Table 19 UK hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
- Table 20 UK hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
- Table 21 Germany hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
- Table 22 Germany hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
- Table 23 Germany hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
- Table 24 France hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
- Table 25 France hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
- Table 26 France hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
- Table 27 Italy hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
- Table 28 Italy hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
- Table 29 Italy hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
- Table 30 Spain hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
- Table 31 Spain hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
- Table 32 Spain hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
- Table 33 Asia Pacific hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
- Table 34 Asia Pacific hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
- Table 35 Asia Pacific hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
- Table 36 Japan hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
- Table 37 Japan hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
- Table 38 Japan hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
- Table 39 China hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
- Table 40 China hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
- Table 41 China hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
- Table 42 India hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
- Table 43 India hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
- Table 44 India hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
- Table 45 Australia hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
- Table 46 Australia hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
- Table 47 Australia hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
- Table 48 South Korea hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
- Table 49 South Korea hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
- Table 50 South Korea hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
- Table 51 Latin America hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
- Table 52 Latin America hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
- Table 53 Latin America hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
- Table 54 Brazil hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
- Table 55 Brazil hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
- Table 56 Brazil hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
- Table 57 Mexico hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
- Table 58 Mexico hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
- Table 59 Mexico hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
- Table 60 Argentina hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
- Table 61 Argentina hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
- Table 62 Argentina hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
- Table 63 Middle East & Africa hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
- Table 64 Middle East & Africa hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
- Table 65 Middle East & Africa hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
- Table 66 South Africa hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
- Table 67 South Africa hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
- Table 68 South Africa hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
- Table 59 Saudi Arabia hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
- Table 70 Saudi Arabia hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
- Table 71 Saudi Arabia hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
- Table 72 UAE hormone replacement therapy market, by product, 2018 - 2030 (USD Billion)
- Table 73 UAE hormone replacement therapy market, by route of administration, 2018 - 2030 (USD Billion)
- Table 74 UAE hormone replacement therapy market, by disease type, 2018 - 2030 (USD Billion)
List of Figures
- Fig. 1 Hormone Replacement Therapy Market Segmentation
- Fig. 2 Market Research Process
- Fig. 3 Information Procurement
- Fig. 4 Primary Research Pattern
- Fig. 5 Market Research Approaches
- Fig. 6 Value-chain-Based Sizing & Forecasting
- Fig. 7 QFD Modeling for Market Share Assessment
- Fig. 8 Market Formulation & Validation
- Fig. 9 Market Summary
- Fig. 10 Penetration & Growth Prospect Mapping
- Fig. 11 Market Driver Impact Analysis (Current & future impact)
- Fig. 12 Market restraint impact analysis (Current & future impact)
- Fig. 13 Porter's Five Forces Analysis
- Fig. 14 HRT market product outlook: Key takeaways
- Fig. 16 Estrogen & progesterone replacement therapy market, 2018 - 2030 (USD Million)
- Fig. 17 HGH replacement therapy market, 2018 - 2030 (USD Million)
- Fig. 18 Thyroid hormone replacement therapy market, 2018 - 2030 (USD Million)
- Fig. 19 Testosterone replacement therapy market, 2018 - 2030 (USD Million)
- Fig. 20 Parathyroid hormone market, 2018 - 2030 (USD Million)
- Fig. 21 HRT market route of administration outlook: Key takeaways
- Fig. 22 HRT market: Route of administration movement analysis
- Fig. 23 Oral market, 2018 - 2030 (USD Million)
- Fig. 24 Parenteral market, 2018 - 2030 (USD Million)
- Fig. 25 Transdermal market, 2018 - 2030 (USD Million)
- Fig. 26 Others market, 2018 - 2030 (USD Million)
- Fig. 27 HRT market disease type outlook: Key takeaways
- Fig. 28 HRT market: Disease type movement analysis
- Fig. 29 Menopause market, 2018 - 2030 (USD Million)
- Fig. 30 Hypothyroidism market, 2018 - 2030 (USD Million)
- Fig. 31 Male hypogonadism market, 2018 - 2030 (USD Million)
- Fig. 32 Growth hormone deficiency market, 2018 - 2030 (USD Million)
- Fig. 33 Hypoparathyroidism, 2018 - 2030 (USD Million)
- Fig. 34 HRT Regional Outlook
- Fig. 35 Regional outlook, 2021 & 2030
- Fig. 36 North America
- Fig. 37 North America market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 38 U.S.
- Fig. 39 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 40 Canada
- Fig. 41 Canada market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 42 Europe
- Fig. 43 Europe market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 44 UK
- Fig. 45 UK market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 46 Germany
- Fig. 47 Germany market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 48 France
- Fig. 49 France market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 50 Spain
- Fig. 51 Spain market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 52 Italy
- Fig. 53 Italy market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 54 Asia-Pacific
- Fig. 55 Asia-Pacific market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 56 Japan
- Fig. 57 Japan market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 58 China
- Fig. 59 China. market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 60 India
- Fig. 61 India market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 62 Australia
- Fig. 63 Australia market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 64 South Korea
- Fig. 65 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 66 Latin America
- Fig. 67 Latin America. market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 68 Brazil
- Fig. 69 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 70 Mexico
- Fig. 71 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 72 Argentina
- Fig. 73 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 74 Middle East & Africa
- Fig. 75 MEA market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 76 South Africa
- Fig. 77 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 78 Saudi Arabia
- Fig. 79 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 80 UAE
- Fig. 81 UAE market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 82 Market differentiators
- Fig. 83 Heat Map Analysis
- Fig. 84 Key company market share analysis, 2021
- Fig. 85 Company market position analysis
- Fig. 86 Company market position analysis
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.